0001628280-23-000454.txt : 20230105
0001628280-23-000454.hdr.sgml : 20230105
20230105160921
ACCESSION NUMBER: 0001628280-23-000454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shiblaq Hisham
CENTRAL INDEX KEY: 0001739363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40797
FILM NUMBER: 23511357
MAIL ADDRESS:
STREET 1: C/O PROCEPT BIOROBOTICS CORPORATION
STREET 2: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp
CENTRAL INDEX KEY: 0001588978
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 260199180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-232-7200
MAIL ADDRESS:
STREET 1: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
wf-form4_167295293970419.xml
FORM 4
X0306
4
2023-01-03
0
0001588978
PROCEPT BioRobotics Corp
PRCT
0001739363
Shiblaq Hisham
C/O PROCEPT BIOROBOTICS CORPORATION
900 ISLAND DRIVE
REDWOOD CITY
CA
94065
0
1
0
0
EVP, Chief Comm. Officer
Common Stock
2023-01-03
4
S
0
9736
39.7594
D
39468
D
Common Stock
2023-01-03
4
S
0
5421
40.4687
D
34047
D
Common Stock
2023-01-03
4
S
0
6306
41.7397
D
27741
D
Common Stock
2023-01-04
4
S
0
466
39.7447
D
27275
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 9, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Includes 931 shares acquired on May 13, 2022 and 500 shares acquired on November 14, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.04 to $41.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.35 to $42.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $40.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
/s/ Alaleh Nouri, Attorney-in-Fact for Hisham Shiblaq
2023-01-05